Stonebridge Capital Advisors Upped Its Gilead Sciences (GILD) Position; Bunge Limited (BG) Covered By 3 Bulls

December 7, 2017 - By Nellie Frank

Stonebridge Capital Advisors Llc increased Gilead Sciences Inc (GILD) stake by 260.64% reported in 2017Q2 SEC filing. Stonebridge Capital Advisors Llc acquired 53,440 shares as Gilead Sciences Inc (GILD)’s stock declined 8.05%. The Stonebridge Capital Advisors Llc holds 73,943 shares with $5.23 million value, up from 20,503 last quarter. Gilead Sciences Inc now has $94.98 billion valuation. The stock decreased 0.79% or $0.58 during the last trading session, reaching $72.71. About 4.51M shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since December 7, 2016 and is downtrending. It has underperformed by 38.50% the S&P500.

Among 9 analysts covering Bunge Limited (NYSE:BG), 3 have Buy rating, 0 Sell and 6 Hold. Therefore 33% are positive. Bunge Limited had 28 analyst reports since July 31, 2015 according to SRatingsIntel. On Wednesday, July 12 the stock rating was maintained by Citigroup with “Buy”. Credit Suisse maintained it with “Hold” rating and $80 target in Friday, May 26 report. The firm has “Neutral” rating given on Monday, March 20 by Goldman Sachs. The stock has “Buy” rating by Piper Jaffray on Thursday, August 3. Citigroup downgraded Bunge Limited (NYSE:BG) on Thursday, September 28 to “Neutral” rating. The stock has “Buy” rating by Piper Jaffray on Friday, July 14. The rating was maintained by Credit Suisse on Friday, May 5 with “Buy”. The stock of Bunge Limited (NYSE:BG) has “Buy” rating given on Friday, October 6 by Piper Jaffray. Robert W. Baird maintained Bunge Limited (NYSE:BG) rating on Friday, October 13. Robert W. Baird has “Hold” rating and $77.0 target. TheStreet downgraded Bunge Limited (NYSE:BG) on Monday, August 3 to “Hold” rating. See Bunge Limited (NYSE:BG) latest ratings:

13/10/2017 Broker: Robert W. Baird Rating: Hold New Target: $77.0 Maintain
06/10/2017 Broker: Piper Jaffray Rating: Buy New Target: $86.0 Maintain
27/09/2017 Broker: BMO Capital Markets Rating: Buy New Target: $87.0 Maintain
28/09/2017 Broker: Citigroup Old Rating: Buy New Rating: Neutral Old Target: $88 Downgrade
11/09/2017 Broker: Robert W. Baird Rating: Hold New Target: $77.0 Initiate
04/09/2017 Broker: Piper Jaffray Rating: Buy New Target: $86.0 Maintain
23/08/2017 Broker: BMO Capital Markets Rating: Buy New Target: $87.0 Maintain
03/08/2017 Broker: Piper Jaffray Rating: Buy New Target: $86.0000 Maintain
20/07/2017 Broker: Piper Jaffray Rating: Buy New Target: $84.0000 Maintain
13/07/2017 Broker: BMO Capital Markets Rating: Buy New Target: $87.0000 Maintain

Investors sentiment increased to 0.93 in Q2 2017. Its up 0.02, from 0.91 in 2017Q1. It is positive, as 78 investors sold GILD shares while 538 reduced holdings. 110 funds opened positions while 462 raised stakes. 938.32 million shares or 0.11% more from 937.32 million shares in 2017Q1 were reported. Rowland & Inv Counsel Adv has invested 0% in Gilead Sciences, Inc. (NASDAQ:GILD). Waverton Invest Management Ltd has invested 0.05% in Gilead Sciences, Inc. (NASDAQ:GILD). Fuller & Thaler Asset stated it has 13,100 shares or 0.01% of all its holdings. 7,249 are held by Reliance Tru Of Delaware. Wolverine Asset Limited Liability stated it has 4,300 shares. 241,625 are held by Madison Investment Hldgs Inc. Peoples Services Corp reported 0.07% stake. Altavista Wealth reported 0.13% stake. Valueworks Ltd Limited Liability Company has 3.79% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 71,478 shares. Bnp Paribas Asset Management Holding owns 0.11% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 170,396 shares. Rodgers Brothers reported 11,475 shares. Shelter Ins Retirement Plan holds 1.5% in Gilead Sciences, Inc. (NASDAQ:GILD) or 45,100 shares. University Of Notre Dame Du Lac has invested 2.13% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Peddock Cap Advisors Limited Company has invested 0.63% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Moreover, Tuttle Tactical Management Limited Liability Company has 0.26% invested in Gilead Sciences, Inc. (NASDAQ:GILD).

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 19 have Buy rating, 0 Sell and 11 Hold. Therefore 63% are positive. Gilead Sciences had 107 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was initiated by Stifel Nicolaus on Monday, November 14 with “Buy”. On Wednesday, February 3 the stock rating was maintained by Credit Suisse with “Outperform”. Oppenheimer maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Wednesday, February 3 with “Outperform” rating. Jefferies maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Friday, October 27 with “Hold” rating. The rating was maintained by RBC Capital Markets with “Outperform” on Monday, October 3. As per Tuesday, July 26, the company rating was downgraded by Needham. The company was initiated on Wednesday, October 4 by Oppenheimer. The firm has “Hold” rating by Jefferies given on Tuesday, July 11. The company was maintained on Monday, August 28 by BMO Capital Markets. The rating was maintained by Bank of America with “Neutral” on Wednesday, October 4.

Investors sentiment decreased to 0.8 in Q2 2017. Its down 0.44, from 1.24 in 2017Q1. It dived, as 69 investors sold Bunge Limited shares while 136 reduced holdings. 61 funds opened positions while 104 raised stakes. 110.83 million shares or 0.16% less from 111.01 million shares in 2017Q1 were reported. Kbc Gru Nv reported 0.02% in Bunge Limited (NYSE:BG). Federated Investors Inc Pa reported 12,195 shares. Boston Ltd Liability Co holds 0.01% or 7,450 shares in its portfolio. Andra Ap stated it has 0.11% of its portfolio in Bunge Limited (NYSE:BG). Lesa Sroufe And accumulated 59,602 shares. Moreover, Hussman Strategic Advisors has 0.83% invested in Bunge Limited (NYSE:BG) for 50,000 shares. Cwm Llc invested 0% of its portfolio in Bunge Limited (NYSE:BG). Globeflex L P accumulated 23,519 shares. Bnp Paribas Arbitrage Sa holds 61,265 shares. First Tru Advsrs Lp holds 0.11% of its portfolio in Bunge Limited (NYSE:BG) for 550,127 shares. Asset One Ltd holds 0.04% or 206,202 shares. Principal, a Iowa-based fund reported 16,173 shares. Fairpointe Ltd Company, Illinois-based fund reported 892,032 shares. Goldman Sachs Grp Inc holds 0.02% in Bunge Limited (NYSE:BG) or 1.15M shares. Zweig, a Alabama-based fund reported 24,541 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com